(KWS) KWS SAAT SE & Co. KGaA - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE0007074007
Corn, Sugarbeet, Cereals, Vegetables
Dividends
| Dividend Yield | 1.86% |
| Yield on Cost 5y | 2.11% |
| Yield CAGR 5y | 9.33% |
| Payout Consistency | 91.8% |
| Payout Ratio | 28.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 24.4% |
| Value at Risk 5%th | 37.4% |
| Relative Tail Risk | -6.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | 10.15 |
| CAGR/Max DD | 0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.375 |
| Beta | 0.048 |
| Beta Downside | 0.214 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.49% |
| Mean DD | 12.52% |
| Median DD | 12.74% |
Description: KWS KWS SAAT SE & Co. KGaA November 11, 2025
KWS SAAT SE & Co. KGaA is a German seed producer that operates across four core segments: Corn (including corn, soybeans, and sunflowers), Sugarbeet (diploid hybrid potatoes and sugar beet seeds), Cereals (rye, wheat, barley, oilseed rape, plus peas, catch crops, and oats), and Vegetables (spinach, beans, Swiss chard, red beet, and tomatoes).
The company’s research footprint includes a 10,000 m² R&D centre, featuring a 6,600 m² greenhouse and dedicated outdoor-vegetable labs, underscoring its emphasis on trait development and climate-resilient varieties.
Founded in 1856 and headquartered in Einbeck, Germany, KWS rebranded to its current legal form in July 2019, maintaining a long-standing presence in the global seed market.
As of FY 2023, KWS reported revenue of roughly €2.1 billion, with an R&D spend of about €200 million (≈9.5% of sales), reflecting industry-average investment intensity. The seed sector is being driven by rising global population (projected 9.7 billion by 2050), increasing demand for sustainable intensification, and accelerating adoption of digital breeding tools-factors that tend to boost seed-price premiums and market consolidation.
For a deeper quantitative view of KWS’s valuation metrics and peer comparison, you may want to explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (157.0m TTM) > 0 and > 6% of Revenue (6% = 99.4m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -2.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 50.00% (prev 50.06%; Δ -0.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 186.6m > Net Income 157.0m (YES >=105%, WARN >=100%) |
| Net Debt (118.9m) to EBITDA (353.4m) ratio: 0.34 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (33.0m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 15.95% (prev 18.12%; Δ -2.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 61.01% (prev 63.80%; Δ -2.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 60.42 (EBITDA TTM 353.4m / Interest Expense TTM 4.60m) >= 6 (WARN >= 3) |
Altman Z'' 5.86
| (A) 0.30 = (Total Current Assets 1.55b - Total Current Liabilities 725.3m) / Total Assets 2.74b |
| (B) 0.54 = Retained Earnings (Balance) 1.48b / Total Assets 2.74b |
| (C) 0.10 = EBIT TTM 277.9m / Avg Total Assets 2.71b |
| (D) 1.36 = Book Value of Equity 1.57b / Total Liabilities 1.16b |
| Total Rating: 5.86 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.60
| 1. Piotroski 5.50pt |
| 2. FCF Yield 7.64% |
| 3. FCF Margin 11.27% |
| 4. Debt/Equity 0.31 |
| 5. Debt/Ebitda 0.34 |
| 6. ROIC - WACC (= 4.33)% |
| 7. RoE 9.97% |
| 8. Rev. Trend -7.14% |
| 9. EPS Trend -22.21% |
What is the price of KWS shares?
As of December 14, 2025, the stock is trading at EUR 67.20 with a total of 15,406 shares traded.
Over the past week, the price has changed by +0.30%, over one month by +4.02%, over three months by +6.28% and over the past year by +15.81%.
Over the past week, the price has changed by +0.30%, over one month by +4.02%, over three months by +6.28% and over the past year by +15.81%.
Is KWS a buy, sell or hold?
KWS SAAT SE & Co. KGaA has no consensus analysts rating.
What are the forecasts/targets for the KWS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 80.3 | 19.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 73.4 | 9.2% |
KWS Fundamental Data Overview December 05, 2025
Market Cap USD = 2.65b (2.27b EUR * 1.1701 EUR.USD)
Market Cap EUR = 2.27b (2.27b EUR * 1.0 EUR.EUR)
P/E Trailing = 13.2625
P/E Forward = 18.1818
P/S = 1.3688
P/B = 1.4221
Beta = 0.54
Revenue TTM = 1.66b EUR
EBIT TTM = 277.9m EUR
EBITDA TTM = 353.4m EUR
Long Term Debt = 277.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 150.9m EUR (from shortLongTermDebt, last quarter)
Debt = 483.5m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 118.9m EUR (from netDebt column, last quarter)
Enterprise Value = 2.44b EUR (2.27b + Debt 483.5m - CCE 309.0m)
Interest Coverage Ratio = 60.42 (Ebit TTM 277.9m / Interest Expense TTM 4.60m)
FCF Yield = 7.64% (FCF TTM 186.6m / Enterprise Value 2.44b)
FCF Margin = 11.27% (FCF TTM 186.6m / Revenue TTM 1.66b)
Net Margin = 9.48% (Net Income TTM 157.0m / Revenue TTM 1.66b)
Gross Margin = 15.95% ((Revenue TTM 1.66b - Cost of Revenue TTM 1.39b) / Revenue TTM)
Gross Margin QoQ = -9.16% (prev -10.37%)
Tobins Q-Ratio = 0.89 (Enterprise Value 2.44b / Total Assets 2.74b)
Interest Expense / Debt = 0.72% (Interest Expense 3.50m / Debt 483.5m)
Taxrate = 30.0% (-4.20m / -14.0m)
NOPAT = 194.6m (EBIT 277.9m * (1 - 30.00%))
Current Ratio = 2.14 (Total Current Assets 1.55b / Total Current Liabilities 725.3m)
Debt / Equity = 0.31 (Debt 483.5m / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 0.34 (Net Debt 118.9m / EBITDA 353.4m)
Debt / FCF = 0.64 (Net Debt 118.9m / FCF TTM 186.6m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.73% (Net Income 157.0m / Total Assets 2.74b)
RoE = 9.97% (Net Income TTM 157.0m / Total Stockholder Equity 1.57b)
RoCE = 15.01% (EBIT 277.9m / Capital Employed (Equity 1.57b + L.T.Debt 277.0m))
RoIC = 9.52% (NOPAT 194.6m / Invested Capital 2.04b)
WACC = 5.19% (E(2.27b)/V(2.75b) * Re(6.19%) + D(483.5m)/V(2.75b) * Rd(0.72%) * (1-Tc(0.30)))
Discount Rate = 6.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 79.57% ; FCFE base≈207.1m ; Y1≈227.0m ; Y5≈289.3m
Fair Price DCF = 152.6 (DCF Value 5.03b / Shares Outstanding 33.0m; 5y FCF grow 10.98% → 3.0% )
EPS Correlation: -22.21 | EPS CAGR: 15.99% | SUE: -0.14 | # QB: 0
Revenue Correlation: -7.14 | Revenue CAGR: 2.14% | SUE: 0.06 | # QB: 0
EPS current Year (2026-06-30): EPS=5.90 | Chg30d=-0.121 | Revisions Net=-1 | Growth EPS=+39.2% | Growth Revenue=+1.4%
EPS next Year (2027-06-30): EPS=5.79 | Chg30d=-0.138 | Revisions Net=-1 | Growth EPS=-1.9% | Growth Revenue=+3.6%
Market Cap EUR = 2.27b (2.27b EUR * 1.0 EUR.EUR)
P/E Trailing = 13.2625
P/E Forward = 18.1818
P/S = 1.3688
P/B = 1.4221
Beta = 0.54
Revenue TTM = 1.66b EUR
EBIT TTM = 277.9m EUR
EBITDA TTM = 353.4m EUR
Long Term Debt = 277.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 150.9m EUR (from shortLongTermDebt, last quarter)
Debt = 483.5m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 118.9m EUR (from netDebt column, last quarter)
Enterprise Value = 2.44b EUR (2.27b + Debt 483.5m - CCE 309.0m)
Interest Coverage Ratio = 60.42 (Ebit TTM 277.9m / Interest Expense TTM 4.60m)
FCF Yield = 7.64% (FCF TTM 186.6m / Enterprise Value 2.44b)
FCF Margin = 11.27% (FCF TTM 186.6m / Revenue TTM 1.66b)
Net Margin = 9.48% (Net Income TTM 157.0m / Revenue TTM 1.66b)
Gross Margin = 15.95% ((Revenue TTM 1.66b - Cost of Revenue TTM 1.39b) / Revenue TTM)
Gross Margin QoQ = -9.16% (prev -10.37%)
Tobins Q-Ratio = 0.89 (Enterprise Value 2.44b / Total Assets 2.74b)
Interest Expense / Debt = 0.72% (Interest Expense 3.50m / Debt 483.5m)
Taxrate = 30.0% (-4.20m / -14.0m)
NOPAT = 194.6m (EBIT 277.9m * (1 - 30.00%))
Current Ratio = 2.14 (Total Current Assets 1.55b / Total Current Liabilities 725.3m)
Debt / Equity = 0.31 (Debt 483.5m / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 0.34 (Net Debt 118.9m / EBITDA 353.4m)
Debt / FCF = 0.64 (Net Debt 118.9m / FCF TTM 186.6m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.73% (Net Income 157.0m / Total Assets 2.74b)
RoE = 9.97% (Net Income TTM 157.0m / Total Stockholder Equity 1.57b)
RoCE = 15.01% (EBIT 277.9m / Capital Employed (Equity 1.57b + L.T.Debt 277.0m))
RoIC = 9.52% (NOPAT 194.6m / Invested Capital 2.04b)
WACC = 5.19% (E(2.27b)/V(2.75b) * Re(6.19%) + D(483.5m)/V(2.75b) * Rd(0.72%) * (1-Tc(0.30)))
Discount Rate = 6.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 79.57% ; FCFE base≈207.1m ; Y1≈227.0m ; Y5≈289.3m
Fair Price DCF = 152.6 (DCF Value 5.03b / Shares Outstanding 33.0m; 5y FCF grow 10.98% → 3.0% )
EPS Correlation: -22.21 | EPS CAGR: 15.99% | SUE: -0.14 | # QB: 0
Revenue Correlation: -7.14 | Revenue CAGR: 2.14% | SUE: 0.06 | # QB: 0
EPS current Year (2026-06-30): EPS=5.90 | Chg30d=-0.121 | Revisions Net=-1 | Growth EPS=+39.2% | Growth Revenue=+1.4%
EPS next Year (2027-06-30): EPS=5.79 | Chg30d=-0.138 | Revisions Net=-1 | Growth EPS=-1.9% | Growth Revenue=+3.6%